Enhanced Electrochemical Characterization of the Immune Checkpoint Protein PD-L1 using Aptamer-Functionalized Magnetic Metal-Organic Frameworks

Programmed death ligand 1 (PD-L1) is highly expressed in cancer cells and participates in the immune escape process of tumor cells. However, as one of the most promising biomarkers for cancer immunotherapy monitoring, the key problem ahead of practical usage is how to effectively improve the detection sensitivity of PD-L1. Herein, an electrochemical aptasensor for the evaluation of tumor immunotherapy is developed based on the immune checkpoint protein PD-L1. The fundamental principle of this method involves the utilization of DNA nanotetrahedron (NTH)-based capture probes and aptamer-modified magnetic metal-organic framework nanocomposites as signaling probes. A synergistic enhancement is observed in the electrocatalytic effect between Fe3O4 and UiO-66 porous shells in Fe3O4@UiO-66 nanocomposites. Therefore, the integration of aptamer-modified Fe3O4@UiO-66@Au with NTH-assisted target immobilization as an electrochemical sensing platform can significantly enhance sensitivity and specificity for target detection. This method enables the detection of targets at concentrations as low as 7.76 pg mL-1 over a wide linear range (0.01 to 1000 ng mL-1). The authors have successfully employed this sensor for in situ characterization of PD-L1 on the cell surface and for monitoring changes in PD-L1 expression during drug therapy, providing a cost-effective yet robust alternative to highly expensive and expertise-dependent flow cytometry.

Hydrogen Sulfide Gas Amplified ROS Cascade: FeS@GOx Hybrid Nanozyme Designed for Boosting Tumor Chemodynamic Immunotherapy

Chemodynamic immunotherapy that utilizes catalysts to produce reactive oxygen species (ROS) for killing tumor cells and arousing antitumor immunity has received considerable attention. However, it is still restricted by low ROS production efficiency and insufficient immune activation, due to intricate redox homeostasis in the tumor microenvironment (TME). Herein, a metalloprotein-like hybrid nanozyme (FeS@GOx) is designed by in situ growth of nanozyme (ferrous sulfide, FeS) in a natural enzyme (glucose oxidase, GOx) to amplify ROS cascade for boosting chemodynamic immunotherapy. In FeS@GOx, GOx allows the conversion of endogenous glucose to gluconic acid and hydrogen peroxide, which provides favorable increasing hydrogen peroxide for subsequent Fenton reaction of FeS nanozymes, thus reinforcing ROS production. Notably, hydrogen sulfide (H2 S) release is activated by the gluconic acid generation-related pH decrease, which can suppress the activity of endogenous thioredoxin reductase and catalase to further inhibit ROS elimination. Thus, FeS@GOx can sustainably amplify ROS accumulation and perturb intracellular redox homeostasis to improve chemodynamic therapy and trigger robust immunogenic cell death for effective immunotherapy combined with immune checkpoint blockade. This work proposes a feasible H2 S amplified ROS cascade strategy employing a bioinspired hybrid nanozyme, providing a novel pathway to multi-enzyme-mediated TME modulation for precise and efficient chemodynamic immunotherapy.

Construct of Carbon Nanotube-Supported Fe2O3 Hybrid Nanozyme by Atomic Layer Deposition for Highly Efficient Dopamine Sensing

The Fe2O3 nanozyme has been identified as the most promising alternative for the Fe3O4 nanozyme due to its relatively low toxic risk and good chemical stability. However, its enzyme-like activity is relatively low enough to meet specific application requirements. Furthermore, previous synthesis approaches have difficulties in fabricating ultra-small Fe2O3 nanoparticles with tunable size and suffer from agglomeration problems. In this study, atomic layer deposition (ALD) was used to deposit Fe2O3 on surfaces of carbon nanotubes to form hybrid nanozymes (Fe2O3/CNTs). ALD enables the preparation of ultrafine Fe2O3 nanoparticles with precise size control <1 nm, while CNTs could be served as promising support for good dispersibility and as an effective activity activator. Hence, the formed Fe2O3/CNTs exhibit excellent peroxidase-like activity with a specific peroxidase activity of 24.5 U mg-1. A colorimetric method for sensing dopamine (DA) was established and presented good sensitivity with a limit of detection (LOD) as low as 0.11 μM. These results demonstrated that, in virtue of meticulous engineering methods like ALD, carbon nanomaterial-based hybrids can be developed as talented enzyme mimetic, thus paving a way for nanozyme design with desired activity and broadening their applications in biosensing and other fields.

In Situ Fabrication of Ultrasmall Gold Nanoparticles/2D MOFs Hybrid as Nanozyme for Antibacterial Therapy

As one of the common reactive oxygen species, H₂ O₂ has been widely used for combating pathogenic bacterial infections. However, the high dosage of H₂ O₂ can induce undesired damages to normal tissues and delay wound healing. In this regard, peroxidase-like nanomaterials serve as promising nanozymes, thanks to their positive promotion toward the antibacterial performance of H₂ O₂ , while avoiding the toxicity caused by the high concentrations of H₂ O₂ . In this work, ultrasmall Au nanoparticles (UsAuNPs) are grown on ultrathin 2D metal-organic frameworks (MOFs) via in situ reduction. The formed UsAuNPs/MOFs hybrid features both the advantages of UsAuNPs and ultrathin 2D MOFs, displaying a remarkable peroxidase-like activity toward H₂ O₂ decomposition into toxic hydroxyl radicals (·OH). Results show that the as-prepared UsAuNPs/MOFs nanozyme exhibits excellent antibacterial properties against both Gram-negative (Escherichia coli) and Gram-positive (Staphylococcus aureus) bacteria with the assistance of a low dosage of H₂ O₂ . Animal experiments indicate that this hybrid material can effectively facilitate wound healing with good biocompatibility. This study reveals the promising potential of a hybrid nanozyme for antibacterial therapy and holds great promise for future clinical applications.